Selected research
Industry Growth & Trends
Global Insulin Needle-free Injection Pen Industry Growth and Trends Forecast to 2032
Market perspective
The global Insulin Needle-free Injection Pen market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Insulin Needle-free Injection Pen is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Insulin Needle-free Injection Pen include Portal Instruments, Injex Pharma, JSK Biomed, Glide Pharma, Antares Pharma, Inc., InsuJet, Miracle Medical, Crossject SA and PharmaJet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Insulin Needle-free Injection Pen market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Insulin Needle-free Injection Pen market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Needle-free Injection Pen market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Needle-free Injection Pen.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Insulin Needle-free Injection Pen market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Insulin Needle-free Injection Pen Market by Company
Portal Instruments
Injex Pharma
JSK Biomed
Glide Pharma
Antares Pharma, Inc.
InsuJet
Miracle Medical
Crossject SA
PharmaJet
Mika Medical
Lepu Medical Technology (Beijing) Co., Ltd.
Shandong Zhongbaokang Medical Equipment Co.,Ltd
Jiangxi Sanxin Medtec Co.,Ltd.
Quinovare
Joyomed Suzhou Co.,Ltd.
Sinocare
Insulin Needle-free Injection Pen Segment by Type
Mechanical Force
Electric Force
Optical Force
Insulin Needle-free Injection Pen Segment by Application
Hospital & Clinic
Retail Pharmacies
Online Channel
Insulin Needle-free Injection Pen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Needle-free Injection Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Needle-free Injection Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Needle-free Injection Pen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insulin Needle-free Injection Pen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Insulin Needle-free Injection Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mechanical Force
- Electric Force
- Optical Force
Applications
- Hospital & Clinic
- Retail Pharmacies
- Online Channel
Companies covered
- Portal Instruments
- Injex Pharma
- JSK Biomed
- Glide Pharma
- Antares Pharma, Inc.
- InsuJet
- Miracle Medical
- Crossject SA
- PharmaJet
- Mika Medical
- Lepu Medical Technology (Beijing) Co., Ltd.
- Shandong Zhongbaokang Medical Equipment Co.,Ltd
- Jiangxi Sanxin Medtec Co.,Ltd.
- Quinovare
- Joyomed Suzhou Co.,Ltd.
- Sinocare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Insulin Needle-free Injection Pen Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Insulin Needle-free Injection Pen Sales Estimates and Forecasts (2021-2032)
- 1.3 Insulin Needle-free Injection Pen Market by Type
- 1.3.1 Mechanical Force
- 1.3.2 Electric Force
- 1.3.3 Optical Force
- 1.4 Global Insulin Needle-free Injection Pen Market Size by Type
- 1.4.1 Global Insulin Needle-free Injection Pen Market Size Overview by Type (2021-2032)
- 1.4.2 Global Insulin Needle-free Injection Pen Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Insulin Needle-free Injection Pen Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Insulin Needle-free Injection Pen Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Insulin Needle-free Injection Pen Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Insulin Needle-free Injection Pen Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Insulin Needle-free Injection Pen Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Insulin Needle-free Injection Pen Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Insulin Needle-free Injection Pen Industry Trends
- 2.2 Insulin Needle-free Injection Pen Industry Drivers
- 2.3 Insulin Needle-free Injection Pen Industry Opportunities and Challenges
- 2.4 Insulin Needle-free Injection Pen Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Insulin Needle-free Injection Pen Revenue (2021-2026)
- 3.2 Global Top Players by Insulin Needle-free Injection Pen Sales (2021-2026)
- 3.3 Global Top Players by Insulin Needle-free Injection Pen Price (2021-2026)
- 3.4 Global Insulin Needle-free Injection Pen Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Insulin Needle-free Injection Pen Major Company Production Sites & Headquarters
- 3.6 Global Insulin Needle-free Injection Pen Company, Product Type & Application
- 3.7 Global Insulin Needle-free Injection Pen Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Insulin Needle-free Injection Pen Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Insulin Needle-free Injection Pen Players Market Share by Revenue in 2025
- 3.8.3 2025 Insulin Needle-free Injection Pen Tier 1, Tier 2, and Tier 3
4 Insulin Needle-free Injection Pen Regional Status and Outlook
- 4.1 Global Insulin Needle-free Injection Pen Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Insulin Needle-free Injection Pen Historic Market Size by Region
- 4.2.1 Global Insulin Needle-free Injection Pen Sales in Volume by Region (2021-2026)
- 4.2.2 Global Insulin Needle-free Injection Pen Sales in Value by Region (2021-2026)
- 4.2.3 Global Insulin Needle-free Injection Pen Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Insulin Needle-free Injection Pen Forecasted Market Size by Region
- 4.3.1 Global Insulin Needle-free Injection Pen Sales in Volume by Region (2027-2032)
- 4.3.2 Global Insulin Needle-free Injection Pen Sales in Value by Region (2027-2032)
- 4.3.3 Global Insulin Needle-free Injection Pen Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Needle-free Injection Pen by Application
- 5.1 Insulin Needle-free Injection Pen Market by Application
- 5.1.1 Hospital & Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Online Channel
- 5.2 Global Insulin Needle-free Injection Pen Market Size by Application
- 5.2.1 Global Insulin Needle-free Injection Pen Market Size Overview by Application (2021-2032)
- 5.2.2 Global Insulin Needle-free Injection Pen Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Insulin Needle-free Injection Pen Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Insulin Needle-free Injection Pen Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Insulin Needle-free Injection Pen Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Insulin Needle-free Injection Pen Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Insulin Needle-free Injection Pen Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Insulin Needle-free Injection Pen Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Portal Instruments
- 6.1.1 Portal Instruments Company Information
- 6.1.2 Portal Instruments Business Overview
- 6.1.3 Portal Instruments Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Portal Instruments Insulin Needle-free Injection Pen Product Portfolio
- 6.1.5 Portal Instruments Recent Developments
- 6.2 Injex Pharma
- 6.2.1 Injex Pharma Company Information
- 6.2.2 Injex Pharma Business Overview
- 6.2.3 Injex Pharma Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Injex Pharma Insulin Needle-free Injection Pen Product Portfolio
- 6.2.5 Injex Pharma Recent Developments
- 6.3 JSK Biomed
- 6.3.1 JSK Biomed Company Information
- 6.3.2 JSK Biomed Business Overview
- 6.3.3 JSK Biomed Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 JSK Biomed Insulin Needle-free Injection Pen Product Portfolio
- 6.3.5 JSK Biomed Recent Developments
- 6.4 Glide Pharma
- 6.4.1 Glide Pharma Company Information
- 6.4.2 Glide Pharma Business Overview
- 6.4.3 Glide Pharma Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Glide Pharma Insulin Needle-free Injection Pen Product Portfolio
- 6.4.5 Glide Pharma Recent Developments
- 6.5 Antares Pharma, Inc.
- 6.5.1 Antares Pharma, Inc. Company Information
- 6.5.2 Antares Pharma, Inc. Business Overview
- 6.5.3 Antares Pharma, Inc. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Antares Pharma, Inc. Insulin Needle-free Injection Pen Product Portfolio
- 6.5.5 Antares Pharma, Inc. Recent Developments
- 6.6 InsuJet
- 6.6.1 InsuJet Company Information
- 6.6.2 InsuJet Business Overview
- 6.6.3 InsuJet Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 InsuJet Insulin Needle-free Injection Pen Product Portfolio
- 6.6.5 InsuJet Recent Developments
- 6.7 Miracle Medical
- 6.7.1 Miracle Medical Company Information
- 6.7.2 Miracle Medical Business Overview
- 6.7.3 Miracle Medical Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Miracle Medical Insulin Needle-free Injection Pen Product Portfolio
- 6.7.5 Miracle Medical Recent Developments
- 6.8 Crossject SA
- 6.8.1 Crossject SA Company Information
- 6.8.2 Crossject SA Business Overview
- 6.8.3 Crossject SA Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Crossject SA Insulin Needle-free Injection Pen Product Portfolio
- 6.8.5 Crossject SA Recent Developments
- 6.9 PharmaJet
- 6.9.1 PharmaJet Company Information
- 6.9.2 PharmaJet Business Overview
- 6.9.3 PharmaJet Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 PharmaJet Insulin Needle-free Injection Pen Product Portfolio
- 6.9.5 PharmaJet Recent Developments
- 6.10 Mika Medical
- 6.10.1 Mika Medical Company Information
- 6.10.2 Mika Medical Business Overview
- 6.10.3 Mika Medical Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Mika Medical Insulin Needle-free Injection Pen Product Portfolio
- 6.10.5 Mika Medical Recent Developments
- 6.11 Lepu Medical Technology (Beijing) Co., Ltd.
- 6.11.1 Lepu Medical Technology (Beijing) Co., Ltd. Company Information
- 6.11.2 Lepu Medical Technology (Beijing) Co., Ltd. Business Overview
- 6.11.3 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Lepu Medical Technology (Beijing) Co., Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 6.11.5 Lepu Medical Technology (Beijing) Co., Ltd. Recent Developments
- 6.12 Shandong Zhongbaokang Medical Equipment Co.,Ltd
- 6.12.1 Shandong Zhongbaokang Medical Equipment Co.,Ltd Company Information
- 6.12.2 Shandong Zhongbaokang Medical Equipment Co.,Ltd Business Overview
- 6.12.3 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Shandong Zhongbaokang Medical Equipment Co.,Ltd Insulin Needle-free Injection Pen Product Portfolio
- 6.12.5 Shandong Zhongbaokang Medical Equipment Co.,Ltd Recent Developments
- 6.13 Jiangxi Sanxin Medtec Co.,Ltd.
- 6.13.1 Jiangxi Sanxin Medtec Co.,Ltd. Company Information
- 6.13.2 Jiangxi Sanxin Medtec Co.,Ltd. Business Overview
- 6.13.3 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Jiangxi Sanxin Medtec Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 6.13.5 Jiangxi Sanxin Medtec Co.,Ltd. Recent Developments
- 6.14 Quinovare
- 6.14.1 Quinovare Company Information
- 6.14.2 Quinovare Business Overview
- 6.14.3 Quinovare Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Quinovare Insulin Needle-free Injection Pen Product Portfolio
- 6.14.5 Quinovare Recent Developments
- 6.15 Joyomed Suzhou Co.,Ltd.
- 6.15.1 Joyomed Suzhou Co.,Ltd. Company Information
- 6.15.2 Joyomed Suzhou Co.,Ltd. Business Overview
- 6.15.3 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Joyomed Suzhou Co.,Ltd. Insulin Needle-free Injection Pen Product Portfolio
- 6.15.5 Joyomed Suzhou Co.,Ltd. Recent Developments
- 6.16 Sinocare
- 6.16.1 Sinocare Company Information
- 6.16.2 Sinocare Business Overview
- 6.16.3 Sinocare Insulin Needle-free Injection Pen Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Sinocare Insulin Needle-free Injection Pen Product Portfolio
- 6.16.5 Sinocare Recent Developments
7 North America by Country
- 7.1 North America Insulin Needle-free Injection Pen Sales by Country
- 7.1.1 North America Insulin Needle-free Injection Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Insulin Needle-free Injection Pen Sales by Country (2021-2026)
- 7.1.3 North America Insulin Needle-free Injection Pen Sales Forecast by Country (2027-2032)
- 7.2 North America Insulin Needle-free Injection Pen Market Size by Country
- 7.2.1 North America Insulin Needle-free Injection Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Insulin Needle-free Injection Pen Market Size by Country (2021-2026)
- 7.2.3 North America Insulin Needle-free Injection Pen Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Insulin Needle-free Injection Pen Sales by Country
- 8.1.1 Europe Insulin Needle-free Injection Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Insulin Needle-free Injection Pen Sales by Country (2021-2026)
- 8.1.3 Europe Insulin Needle-free Injection Pen Sales Forecast by Country (2027-2032)
- 8.2 Europe Insulin Needle-free Injection Pen Market Size by Country
- 8.2.1 Europe Insulin Needle-free Injection Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Insulin Needle-free Injection Pen Market Size by Country (2021-2026)
- 8.2.3 Europe Insulin Needle-free Injection Pen Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Insulin Needle-free Injection Pen Sales by Country
- 9.1.1 Asia-Pacific Insulin Needle-free Injection Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Insulin Needle-free Injection Pen Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Insulin Needle-free Injection Pen Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Insulin Needle-free Injection Pen Market Size by Country
- 9.2.1 Asia-Pacific Insulin Needle-free Injection Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Insulin Needle-free Injection Pen Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Insulin Needle-free Injection Pen Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Insulin Needle-free Injection Pen Sales by Country
- 10.1.1 South America Insulin Needle-free Injection Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Insulin Needle-free Injection Pen Sales by Country (2021-2026)
- 10.1.3 South America Insulin Needle-free Injection Pen Sales Forecast by Country (2027-2032)
- 10.2 South America Insulin Needle-free Injection Pen Market Size by Country
- 10.2.1 South America Insulin Needle-free Injection Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Insulin Needle-free Injection Pen Market Size by Country (2021-2026)
- 10.2.3 South America Insulin Needle-free Injection Pen Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Insulin Needle-free Injection Pen Sales by Country
- 11.1.1 Middle East and Africa Insulin Needle-free Injection Pen Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Insulin Needle-free Injection Pen Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Insulin Needle-free Injection Pen Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Insulin Needle-free Injection Pen Market Size by Country
- 11.2.1 Middle East and Africa Insulin Needle-free Injection Pen Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Insulin Needle-free Injection Pen Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Insulin Needle-free Injection Pen Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Insulin Needle-free Injection Pen Value Chain Analysis
- 12.1.1 Insulin Needle-free Injection Pen Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Insulin Needle-free Injection Pen Production Mode & Process
- 12.2 Insulin Needle-free Injection Pen Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Insulin Needle-free Injection Pen Distributors
- 12.2.3 Insulin Needle-free Injection Pen Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst